Work

Phase II trial of neoadjuvant bevacizumab with modified FOLFOX7 (BEVmFOLFOX) in Patients (pts) with stage II and III rectal adenocarcinoma (RCA)

Year: 2017

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx261.357

Authors: Afsaneh Barzi, Dongyun Yang, Ramona Lujan, Dana Agafitei, Anthony El-Khoueiry, Syma Iqbal, Diana Hanna, Adrian Ortega, Andreas Kaiser, Kyle Cologne, Sang Lee, Heinz-Josef Lenz

Institutions: University of Southern California, USC Norris Comprehensive Cancer Center

Language: English

Topic: Colorectal Cancer Surgical Treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2725235490

FWCI:

Cites:

Cited by:

Related to: 10